Friday, February 3, 2012
Diabetes
Metformin May Lower Diabetics’ Odds for Pancreatic CancerSUNDAY, Aug. 2 (HealthDay News) — Metformin, one of the most widely used diabetes drugs, may offer patients the added benefit of lowering their odds for pancreatic cancer by 60 percent, a new study shows.But the study had a downside: Other common treatments, including the use of insulin or insulin-releasing medications such
Subscribe to:
Post Comments (Atom)
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
No comments:
Post a Comment